Table 1 Patient characteristics
From: Report on planning comparison of VMAT, IMRT and helical tomotherapy for the ESCALOX-trial pre-study
Characteristics | GTV = SIB77Gy (cm3) |
|---|---|
Patient 1, male Age at diagnosis: 67 years Diagnosis: OPC (midline of base of tongue) TNM: cT3 cN2b cM0 G3 Histology: SCC, p16+ Treatment: CCRT once Cisplatin 40 mg/m2/day, change to 5× Carboplatin AUC 2 (only one kidney after accident) | 86.8 |
Patient 2, male Age at diagnosis: 70 years Diagnosis: OPC (base of tongue right) TNM: cT2 cN2c cM0 G3 Histology: SCC, p16− Treatment: CCRT with 4× Cisplatin 40 mg/m2/day | 77.33 |
Patient 3, male Age at diagnosis: 53 years Diagnosis: OPC (left soft palate, base of tongue, tongue left side, floor of mouth, exceeding midline) TNM: cT4a cN2c cM0 G3 Histology: SCC, p16− Treatment: CCRT with 6× Cisplatin 40 mg/m2/day | 116.4 |
Patient 4, male Age at diagnosis: 54 years Diagnosis: OPC (left tonsil, submandibular gland, dorsal third of tongue, fossa pterygopalatina) TNM: cT4a cN2c cM0 G3 Histology: SCC, p16− Treatment: CCRT with 6× Cisplatin 40 mg/m2/day | 24.6 |
Patient 5, male Age at diagnosis: 56 years Diagnosis: OPC (left tonsil and fossa) TNM: cT2 cN2b cM0 G2 Histology: SCC, p16− Treatment: CCRT with 6× Cisplatin 40 mg/m2/day | 48.3 |
Patient 6, male Age at diagnosis: 68 years Diagnosis: OPC (right tonsil and soft palate) TNM: cT4a cN2b cM0 G3 Histology: SCC, p16− Treatment: CCRT with 3× Cisplatin 40 mg/m2/day | 22.4 |